Literature DB >> 24366079

Deficiency of the interleukin 17/23 axis accelerates renal injury in mice with deoxycorticosterone acetate+angiotensin ii-induced hypertension.

Christian F Krebs1, Sascha Lange, Gianina Niemann, Alva Rosendahl, Alexander Lehners, Catherine Meyer-Schwesinger, Rolf A K Stahl, Ralf A Benndorf, Joachim Velden, Hans-Joachim Paust, Ulf Panzer, Heimo Ehmke, Ulrich O Wenzel.   

Abstract

T cells participate in angiotensin II (Ang II)-induced hypertension. However, the specific subsets of T cells that are important in the end-organ damage are unknown. T-helper 17 cells are a recently identified subset that produces interleukin 17 (IL-17) and requires interleukin 23 (IL-23) for expansion. To evaluate the role of the T-helper 17 immune response in hypertensive renal and cardiac end-organ damage, hypertension was induced with deoxycorticosterone acetate (DOCA)+Ang II in wild-type (n=39) and IL-17-deficient (n=31) mice. The injury was evaluated at day 4 and day 14. To inactivate the IL-17/IL-23 axis at a different point, DOCA+Ang II hypertension was also induced in IL-23p19-deficient mice. Renal infiltration by T-helper 17 cells was increased in hypertensive wild-type mice. Systolic blood pressure did not differ between hypertensive IL-17-deficient and wild-type mice. Three days after induction of hypertension, a significantly higher albuminuria was found in IL-17-deficient than in wild-type mice (196±64 versus 58±16 mg/mg albumin/creatinine). Histology revealed significantly more glomerular injury (1.04±0.06 versus 0.67±0.05) and renal infiltration of γδ T cells in IL-17-deficient than in wild-type mice after 14 days. Similarly, significantly higher albuminuria, glomerular injury, and γδ T cell infiltration were found in IL-23p19-deficient mice with DOCA+Ang II-induced hypertension. DOCA+Ang II also induced cardiac damage as assessed by heart weight, cardiac fibrosis, as well as expression of fetal genes and matrix components, but no significant differences were found among IL-17(-/-), IL-23p19(-/-), and wild-type mice. IL-17/IL-23 deficiency accelerates DOCA+Ang II-induced albuminuria and hypertensive renal but not cardiac end-organ damage.

Entities:  

Keywords:  albuminuria; angiotensin II; desoxycorticosterone acetate; interleukin-17; interleukin-23

Mesh:

Substances:

Year:  2013        PMID: 24366079     DOI: 10.1161/HYPERTENSIONAHA.113.02620

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  39 in total

1.  Paradoxical Role of IL-17 in Progression of Diabetic Nephropathy.

Authors:  Daniel L Galvan; Farhad R Danesh
Journal:  J Am Soc Nephrol       Date:  2015-09-02       Impact factor: 10.121

Review 2.  Immune Mechanisms in Arterial Hypertension.

Authors:  Ulrich Wenzel; Jan Eric Turner; Christian Krebs; Christian Kurts; David G Harrison; Heimo Ehmke
Journal:  J Am Soc Nephrol       Date:  2015-08-28       Impact factor: 10.121

Review 3.  Role of immune cells in hypertension.

Authors:  Antoine Caillon; Pierre Paradis; Ernesto L Schiffrin
Journal:  Br J Pharmacol       Date:  2018-07-20       Impact factor: 8.739

Review 4.  Interleukin-17: Friend or foe in organ fibrosis.

Authors:  Kritika Ramani; Partha S Biswas
Journal:  Cytokine       Date:  2019-02-14       Impact factor: 3.861

Review 5.  Renal effects of cytokines in hypertension.

Authors:  Yi Wen; Steven D Crowley
Journal:  Curr Opin Nephrol Hypertens       Date:  2018-03       Impact factor: 2.894

Review 6.  Inflammation, immunity, and hypertensive end-organ damage.

Authors:  William G McMaster; Annet Kirabo; Meena S Madhur; David G Harrison
Journal:  Circ Res       Date:  2015-03-13       Impact factor: 17.367

Review 7.  Role of the Immune System in Hypertension.

Authors:  Bernardo Rodriguez-Iturbe; Hector Pons; Richard J Johnson
Journal:  Physiol Rev       Date:  2017-07-01       Impact factor: 37.312

8.  Adaptive immunity and IL-17A are not involved in the progression of chronic kidney disease after 5/6 nephrectomy in mice.

Authors:  Alva Rosendahl; Reza Kabiri; Marlies Bode; Anna Cai; Stefanie Klinge; Heimo Ehmke; Hans-Willi Mittrücker; Ulrich O Wenzel
Journal:  Br J Pharmacol       Date:  2018-12-18       Impact factor: 8.739

Review 9.  T-cell involvement in sex differences in blood pressure control.

Authors:  G Ryan Crislip; Jennifer C Sullivan
Journal:  Clin Sci (Lond)       Date:  2016-05-01       Impact factor: 6.124

Review 10.  Salt, inflammation, IL-17 and hypertension.

Authors:  Ulrich O Wenzel; Marlies Bode; Christian Kurts; Heimo Ehmke
Journal:  Br J Pharmacol       Date:  2018-06-15       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.